Skip to main content

Gemcitabine for patients with relapsed nasopharyngeal carcinoma

Buy Article:

$51.00 plus tax (Refund Policy)

Document Type: Research Article

DOI: http://dx.doi.org/10.1046/j.1445-5994.2002.00207.x

Affiliations: Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia

Publication date: May 1, 2002

bsc/imj/2002/00000032/F0020005/art00016
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more